Type 2 & other diabetes

Nomogram‐based prediction of hypoglycemia risk in elderly community‐dwelling patients with type 2 diabetes: Development and validation in a multicentre real‐world cohort

Diabetes Obes MetabPublished Prognostic model development and internal validation study

Authors' conclusion

This nomogram accurately quantifies the 6-month risk of hypoglycemia in elderly community-dwelling T2DM patients. It provides evidence-based decision support for hypoglycemia prevention in primary healthcare settings and may assist community physicians in delivering individualised chronic disease management.

Study context

Population
Elderly community-dwelling patients with T2D, five community health centres, recruited 1 March–31 May 2024
Participants
815 patients
Outcome
First hypoglycemic event during follow-up
Follow-up
6 months
Methodological detailsprospective cohort, multicentre, real-world data, least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression, bootstrap internal validation, Followed 6 months after enrolment
  • Prospective cohort
  • Multicentre
  • Real-world data
  • LASSO and multivariable logistic regression
  • Bootstrap internal validation
  • Followed 6 months after enrolment

Performance

As reported in the abstract

6-month cumulative incidence of hypoglycemia

17.5%

Model AUC (good calibration and clinical utility)

0.80

Independent predictors in final model: history of hypoglycemia, HbA1c, BMI, self-management ability, living situation, exercise intensity, frequency of glucose monitoring, medication use, insulin use, hypoglycemia fear-behaviour scale score

10

Original publication

Nomogram‐based prediction of hypoglycemia risk in elderly community‐dwelling patients with type 2 diabetes: Development and validation in a multicentre real‐world cohort. Diabetes Obes Metab. Published 17 November 2025. doi:10.1111/dom.70297

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.